Connect Biopharma Hldgs Financials - Benzinga

Connect Biopharma Holdings Ltd

CNTBNASDAQ

Trade with Public

Trade with Public

$1.10

0.032.8%

近くで: Sep 23, 5:00 PM EST

$1.10

0.032.8%

プレマーケット: 4:00 AM EST

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Connect Biopharma Hldgs Financials

Connect Biopharma Hldgs (CNTB) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Connect Biopharma Hldgs Q2 EPS $(0.27) Beats $(0.31) Estimate, Sales $2.768M Beat $650.000K Estimate

Benzinga Newsdesk

PRO
Connect Biopharma Hldgs Q1 EPS $(0.34) Misses $(0.28) Estimate, Sales $169.000K

Connect Biopharma Hldgs (NASDAQ:CNTB) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.28) by 21.43 percent. This is a 78.95 percent decrease over losses of $(0.19) per

Benzinga Newsdesk

PRO
Connect Biopharma Hldgs Q4 EPS $(0.27) Beats $(0.30) Estimate

Connect Biopharma Hldgs (NASDAQ:CNTB) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.30) by 10 percent. This is a 68.75 percent decrease over losses of $(0.16) per share

Benzinga Newsdesk

PRO
Connect Biopharma Hldgs Q3 EPS $(0.31) Misses $(0.27) Estimate, Sales $16.000K Down From $1.219M YoY

Connect Biopharma Hldgs (NASDAQ:CNTB) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.27) by 14.81 percent. This is a 34.78 percent decrease over losses of $(0.23) per

Benzinga Newsdesk

PRO
Connect Biopharma Hldgs Q2 EPS $(0.23) Misses $(0.22) Estimate, Sales $48.000K Down From $24.116M YoY

Connect Biopharma Hldgs (NASDAQ:CNTB) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.22) by 4.55 percent. This is a 185.19 percent decrease over earnings of $0.27 per

Benzinga Newsdesk

PRO
Connect Biopharma Hldgs Q1 EPS $(0.19) Down From $(0.16) YoY

Connect Biopharma Hldgs (NASDAQ:CNTB) reported quarterly losses of $(0.19) per share. This is a 18.75 percent decrease over losses of $(0.16) per share from the same period last year.

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved